March 20, 2008 MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) firstname.lastname@example.org Berlin Fire Brigade Equipped with ZOLL AutoPulse Non-Invasive Cardiac Support Pumps March 20, 2008—Chelmsford, MASS.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that the Federal State of Berlin has equipped all of the Doctor’s Ambulance vehicles and the Fire Brigade Training Center in the City of Berlin with AutoPulse® Non-invasive Cardiac Support Pumps. The German capital, with around 3.3 million citizens, is the largest city in Germany and also has the country’s largest fire brigade organization. Michael Toursarkissian, M.D., a Director of the Working Committee of EMS Physicians Berlin and Senior Physician for Anaesthesia and ICU at Red Cross Hospital Berlin, recommended the purchase following successful use and a number of saved lives after two years of trialing the device. He has reported the successful clinical outcomes with AutoPulse at several medical congresses and symposia in Germany. Winfried Gräfling, Berlin´s Chief Fire Officer, approved the purchase. AutoPulse helps provide the consistent, uninterrupted chest compressions called for by the 2005 American Heart Association and European Resuscitation Council Guidelines. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes a wider area of the chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest. Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions. “We’re extremely pleased that the fire brigade of Berlin has recognized the contribution AutoPulse makes in helping to save the lives of SCA victims by delivering consistent, high-quality chest compressions,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “AutoPulse moves more blood more effectively than manual compressions, thereby providing the best possible patient care.” About Sudden Cardiac Arrest The human toll from SCA is alarming with more than 1 million deaths occurring annually worldwide. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See Thru CPR™, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com. Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on February 5, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements. Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, LifeBand, and Real CPR Help are registered trademarks of ZOLL Medical Corporation. See-Thru CPR is a trademark of ZOLL Medical Corporation. All product names are the property of their respective owners.